Effect of intravitreal dexamethasone on macular edema in von Hippel-Lindau disease assessed using swept-source optical coherence tomography: a case report.
Angelo Maria MinnellaValeria PaglieiMartina MaceroniMatteo FedericiGloria GambiniAldo CaporossiPublished in: Journal of medical case reports (2018)
In our experience, intravitreal dexamethasone administration has proven to be a useful tool for reducing retinal hemangioblastoma-related macular edema in von Hippel-Lindau disease and may be considered a potentially valuable treatment that can be used in combination with other therapies.